CNBC-TV18 executive editor Shereen Bhan and Archana Shukla reports that Malvinder Singh, while denying all wrong-doing at Ranbaxy, says that Daiichi took months to clinch the deal and the due diligence process was rigourously followed.
first published: May 23, 2013 08:40 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Clocks Second Week Of Gains But Still Awaits New Peak;Midcaps Snap 7-Week Run|Closing Bell
Will Nifty Bulls March Towards Fresh Peak Despite Dismal Global Cues? | Opening Bell Live
Nifty Aims For Next 26,100 After Hitting 3-Week High |Opening Bell Live
Nifty Back Above 26,000 As IT Stocks Sprint Ahead; Nvidia Earnings In Focus| Closing Bell Live
